Cookies on this website

We use cookies to ensure that we give you the best experience on our website. If you click 'Accept all cookies' we'll assume that you are happy to receive all cookies and you won't see this message again. If you click 'Reject all non-essential cookies' only necessary cookies providing core functionality such as security, network management, and accessibility will be enabled. Click 'Find out more' for information on how to change your cookie settings.

David Lyreskog

PhD


Senior Researcher in Neuroethics

About me

I am a Senior Researcher with the Neuroscience, Ethics & Society (NEUROSEC) team in the Department of Psychiatry, and my current key roles include:

- Deputy Director of the Design Bioethics Laboratory, with the Neuroscience, Ethics & Society (NEUROSEC) team at the Department of Psychiatry, University of Oxford, and the Wellcome Discovery Platform 'ANTITHESES'.

- Co-Investigator on the Horizon Europe project 'AI-PROGNOSIS' – an international and multidisciplinary effort to develop an ethical ecosystem for diagnosis, prognosis, and disease management in Parkinson's Disease using Big Data and AI.

- Lead Researcher on the Wellcome Ethics & Humanities research line 'Rethinking Collective Minds', investigating conceptual and ethical impacts of emerging technologies for collective thinking and decision-making.

-

My background being in the field of analytic philosophy, I have a MA in Philosophy from Umeå University, Sweden. My Magistrate (1 year MA) thesis explored the landscape of moral enhancement as a means for criminal rehabilitation (2013), and my Masters (2 year MA) thesis discussed ethical issues in decision-making processes leading up to deep brain stimulation (DBS) in paediatric populations (2014).

My PhD thesis, The Ethics of Mind Maintenance (2020), analysed ethical trade-offs in the context of emerging technologies aimed at preventing and treating age-related neural decline and disease. The project sought to facilitate our understanding of the value trade-offs involved in utilising technologies for neurodegenerative diseases, the aim being to provide a guiding and ethically sound decision-making structure for patients and other users of the technologies.

Between 2019 and 2021 I worked on the Wellcome-funded project BeGOOD Early Intervention Ethics in Child and Adolescent Mental Health, developing novel tools for bioethics research and engagement with young people. In this project, we built a digital game – 'Tracing Tomorrow' – to study the values and preferences of young people in the context of digital phenotyping for mental health in schools.

-

While I am broadly interested in impactful research and innovation in the intersection of neuroscience, psychiatry, and technology, specific domains of interests include ethical analysis, decision-making, and innovation in:
* New and emerging neurotechnologies;
* Mental health in child and adolescent populations;
* Exercise, sports, and health;
* Diagnosis, prevention, and treatment strategies for neurodegenerative disease;
* Frailty and multimorbidity;
* Artificial, Hybrid, and Collective Intelligence.